BioNTech SE (BNTX) Liabilities and Shareholders Equity (2018 - 2026)

BioNTech SE has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $25.6 billion in Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 6.32% year-over-year to $25.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $97.3 billion (up 0.53% YoY) and the FY2025 annual result came in at $24.8 billion, up 3.19% from the prior year.
• Liabilities and Shareholders Equity climbed to $25.6 billion in Q4 2025 per BNTX's latest filing, from $24.9 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $25.6 billion in Q4 2025 and troughed at $5.1 billion in Q1 2021.
• A 5-year average of $21.7 billion and a median of $23.8 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2021 and 2025: Liabilities and Shareholders Equity jumped 927.56% in 2021, then fell 7.85% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $18.1 billion in 2021, then jumped by 31.15% to $23.8 billion in 2022, then grew by 4.22% to $24.8 billion in 2023, then slipped by 2.74% to $24.1 billion in 2024, then grew by 6.32% to $25.6 billion in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $25.6 billion, $24.9 billion, and $24.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.